Tolemy Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.64M

  • Investors
  • 6

Tolemy Bio General Information

Description

Operator of a biotechnology company intended to program cell metabolism for biomanufacturing. The company's technology uses metabolic modeling and minimal data to create uniquely designed cell culture media and offers solutions like cell-line and process data generation, model-driven prediction of cell culture media, and small-batch custom media manufacture, enabling researchers to efficiently manufacture advanced therapies through bespoke media design.

Contact Information

Website
www.tolemy.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Future Business Centre
  • Kings Hedges Road
  • Cambridge CB4 2HY
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Manufacturing, Digital Health, SaaS, HealthTech, Life Sciences
Corporate Office
  • Future Business Centre
  • Kings Hedges Road
  • Cambridge CB4 2HY
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tolemy Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 12-May-2026 $1.64M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Tolemy Bio’s complete valuation and funding history, request access »

Tolemy Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tolemy Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Big Sur Ventures Venture Capital Minority
JME Venture Capital Venture Capital Minority
Masia Venture Capital Minority
Norrsken Evolve Accelerator/Incubator Minority
Redbus Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Tolemy Bio FAQs

  • When was Tolemy Bio founded?

    Tolemy Bio was founded in 2024.

  • Where is Tolemy Bio headquartered?

    Tolemy Bio is headquartered in Cambridge, United Kingdom.

  • What is the size of Tolemy Bio?

    Tolemy Bio has 4 total employees.

  • What industry is Tolemy Bio in?

    Tolemy Bio’s primary industry is Biotechnology.

  • Is Tolemy Bio a private or public company?

    Tolemy Bio is a Private company.

  • What is Tolemy Bio’s current revenue?

    The current revenue for Tolemy Bio is .

  • How much funding has Tolemy Bio raised over time?

    Tolemy Bio has raised $1.64M.

  • Who are Tolemy Bio’s investors?

    Big Sur Ventures, JME Venture Capital, Masia, Norrsken Evolve, and Redbus Ventures are 5 of 6 investors who have invested in Tolemy Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process